RE:RE:RE:RE:RE:RE:RE:Addressable market Thanks for that clarification as I had a brain freeze and thought IM was SC. Sorry that you are reminded of the difference every month but glad to see you posting here still. Hopefully, there will be more TH-1902 stuff to post about in the not too distant future and I am trusting your health remains stable or improving.
jfm1330 wrote: A patient cannot inject himself an intra-muscular drug. I had IM injections every month for the last seven years and it had to be performed by a nurse, either at home, or in a clinic. I recently switched to another injectable drug which is given by what they call deep subcutaneous injection. The injection site is on the side of the hip/buttock. I was given the choice to learn to do it myself or to have a nurse coming to my home every month to do it. I chose the nurse. I don't fear injections, but given the choice, the nurse was the better option. That being said, deep subcutaneous is much more patient friendly than IM, it's almost painless, while with IM you ended up with a little bruise like pain for 2 to 3 days.
SPCEO1 wrote: Yes, I believe that is correct. And it could prove very helpful to sales but it is still hard to beat a pill even then. That data reported yesterday, however, if THTX is able to communicate it effectively to doctors, may be enough for patients to be willing to take the Trogarzo shot over competing pills. But don't expect immediate results on the Trogarzo sales front as it will take time for that data to be spread to doctors and my guess is patients are still likely to opt for pills unless their doctor makes a really convincing case to them. Some doctors will and some won't. So, it should help Trogarzo sales but time will tell by how much.
LouisW wrote: Your "simple at home" comment really interests me. Are you saying IM can be performed at home by themself? Patients no need to go to hospital?